The new KV3.4 inhibitor BDS-I[1–8]
as a potential pharmacological
opportunity in Alzheimer’s disease
therapy
Ilaria Piccialli#
, Roselia Ciccone#
, Anna Pannaccione*
Division of Pharmacology, Department of Neuroscience,
Reproductive and Dentistry Sciences, School of Medicine, Federico
II University of Naples, Napoli, Italy
Online:2020-07-15
Published:2020-09-12
Contact:
Anna Pannaccione, PhD, pannacio@unina.it.
#Both authors contributed equally to this work.
Ilaria Piccialli# , Roselia Ciccone# , Anna Pannaccione. The new KV3.4 inhibitor BDS-I[1–8]
as a potential pharmacological
opportunity in Alzheimer’s disease
therapy[J]. Neural Regeneration Research, 2020, 15(7): 1255-1256.